Skip to main content
XTL Biopharmaceuticals Ltd. logo

XTL Biopharmaceuticals Ltd. — Investor Relations & Filings

Ticker · XTLB ISIN · IL0010854979 LEI · 529900NDDXEAPTUTXP41 TA Manufacturing
Open in API
Filings indexed 1,223 across all filing types
Latest filing 2005-07-07 Report Publication Anno…
Country IL Israel
Listing TA XTLB

About XTL Biopharmaceuticals Ltd.

https://www.xtlbio.com

XTL Biopharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the acquisition and development of pharmaceutical products to address unmet clinical needs. The company's primary therapeutic area of interest is autoimmune diseases. Its development pipeline has included proprietary drug candidates for conditions such as Systemic Lupus Erythematosus (SLE).

Recent filings

Filing Released Lang Actions
Immediate report on other matter
Report Publication Announcement Classification · 98% confidence The document is very short (1598 characters) and contains a clear header indicating an 'Immediate report on other matter'. Crucially, it explicitly states 'Convening of AGM and EGM' and references an 'Attached file *AGMEGMNotice06jul05_isa.pdf*'. According to Rule 2 (The 'MENU VS MEAL' Rule), when a short document announces the publication of a report or notice, it should be classified as a Report Publication Announcement (RPA) rather than the underlying report itself. Since this document announces the convening of an AGM/EGM, it is an announcement regarding a meeting notice.
2005-07-07 English
Immediate report on other matter
Regulatory Filings Classification · 95% confidence The document is a Registration Document filed with the Israel Securities Authority in connection with the dual listing of XTL Biopharmaceuticals Ltd shares on the Tel Aviv Stock Exchange. It includes detailed company information, share descriptions, regulatory approvals, and references to the company's prospectus and articles of association. The document is not an annual or interim financial report, nor is it an earnings release or a management discussion. It is a formal regulatory filing related to securities registration and listing, which does not fit into categories like Annual Report, Interim Report, or Capital/Financing Update. Given the nature of the document as a registration document for trading and listing, the most appropriate classification is Regulatory Filings (RNS). The document length (8891 characters) and content confirm it is not a brief announcement but a substantive regulatory filing. Therefore, the classification is RNS with high confidence.
2005-07-07 Hebrew (modern)
Immediate report on other matter
Report Publication Announcement Classification · 98% confidence The document is very short (1577 characters) and contains a header indicating it is an 'Immediate report on other matter'. Crucially, it states 'Attached file LISTING_isa.pdf'. According to Rule 2 (The 'MENU VS MEAL' Rule), when a document is short and announces that a report is attached or published, it should be classified as a Report Publication Announcement (RPA) rather than the report itself. The content suggests a regulatory filing announcement, but RPA is more specific for announcing the publication of an attached file/report.
2005-07-07 English
Registration Document
Capital/Financing Update Classification · 95% confidence The document is titled 'Registration Document' and relates to the registration for trading of shares of XTL Biopharmaceuticals Ltd. It includes detailed information about the company, share capital, stock exchange listings, and approvals from the Tel-Aviv Stock Exchange. It also references a prospectus and various reports and press releases. The document is dated July 7, 2005, and is related to the listing and trading of shares, including an open offer and private placements. This type of document is typically a registration statement or prospectus related to capital raising and listing of securities, which aligns with a Capital/Financing Update rather than a full annual report or other categories. It is not a financial report, earnings release, or management report, but rather a detailed announcement and documentation related to capital raising and share registration. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2005-07-07 Hebrew (modern)
Registration Document
Report Publication Announcement Classification · 95% confidence The document text appears to be a regulatory filing notification, likely from the Israel Securities Authority (ISA) or Tel Aviv Stock Exchange (TASE), given the headers and contact information. Key phrases include 'Registration Document', 'Class of securities to be listed for trade', 'Date of Registration Document 07/07/2005', and the explicit mention: 'Attached hereto is a file containing the Registration Document REGISTRATION_isa.pdf'. This structure—a brief notification announcing the availability of a larger document (the Registration Document)—strongly suggests a Report Publication Announcement (RPA), especially since the document length is short (3330 chars) and it points to an attachment rather than containing the full report content itself. A Registration Document often precedes a listing or major corporate action, but the immediate filing type here is the announcement of its publication.
2005-07-07 English
Regulatory Filings 2005
Regulatory Filings Classification · 95% confidence The document is a detailed comment letter from a regulatory body (likely the SEC) reviewing a Form 20-FR12G filing by XTL Biopharmaceuticals Ltd. It contains extensive comments on disclosures, risk factors, clinical trial data, intellectual property, and financial conditions. The letter references the Form 20-FR12G registration statement and requests revisions and additional disclosures. This is not the filing itself but a regulatory review letter commenting on the filing. The document is lengthy (15,000 characters) but is clearly a regulatory review letter, not a financial report or earnings release. It does not contain financial statements or management discussion but is a regulatory filing related to the registration statement review process. Therefore, the best classification is Regulatory Filings (RNS), which covers general regulatory announcements, compliance documents, and officer certifications or review letters that do not fit other categories.
2005-06-08 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.